BioMarin Pharmaceutical (NASDAQ:BMRN)

investing

Cowen Raises Price Targets on Focus Call Stocks to Buy

The higher the market goes, the more stock investors have to be focused on owning stocks that could continue to grow earnings and outperform. Typically in a big market correction, ...
Read Full Story »
biotech

3 Biotech Stocks to Buy With Huge Catalysts Coming Soon

Biotech investors are a hearty lot. They need to be because often a company's success or failure can rely on a single positive clinical outcome. A new report from SunTrust ...
Read Full Story »
amgnlogo

4 Large Cap Biotech Stocks to Buy Before Earnings

The biotech industry has been on an outstanding run over the past year, and some top analysts on Wall Street think that run could be poised to continue. A new ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: BioMarin, BP, Micron, Vonage, Finisar, ConEd, Red Hat and More

Stocks were indicated marginally higher on Friday morning, a day after the Nasdaq finally took out its all-time highs from March of 2000. One constant over the past three and ...
Read Full Story »
buy sell

3 Drivers Supporting BioMarin

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has three key drivers helping out its shares on Thursday. The first is solid news on its drug aimed at dwarfism. The second driver is ...
Read Full Story »
American flag

Analyst Has 4 Top US Growth Stock Calls for This Week

While the short week is always nice for those needing a break, it also tends to compact the research calls and data that come out into a shorter space. A ...
Read Full Story »
biotech

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

There should be no surprise to biotech investors that the mergers and acquisition (M&A) market and chatter are heating up. The huge buy of Synageva Biopharma Corp. (NASDAQ: GEVA) by ...
Read Full Story »
Biotechnology word cloud

Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks

Combine the upcoming typical summer weakness with howls of a biotech bubble, and the recipe is in place for trouble, even for the top stocks in the industry. In a ...
Read Full Story »
Biotechnology word cloud

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

The XBI, which is the S&P 500 biotech index, has been hit hard this week and is down almost 14% since last Friday. While still up big over the past ...
Read Full Story »
Euro

How the Weaker Euro Is Impacting Biotech Earnings

It is no secret that a strong dollar and a weak euro, and foreign currency environment, are acting to hurt U.S. corporate earnings. Many investors might think that biotech earnings ...
Read Full Story »
Pills

The Next 3 Likely Biotech Buyout Candidates

One good way for a company to increase sales and move past simple organic growth is to make an acquisition, and that is just what AbbVie Inc. (NYSE: ABBV) did ...
Read Full Story »
uncertainty market evolution

Cowen Raises Price Targets on Top Momentum Stocks

As the market continues its march higher, investors are starting to look for the stocks that are delivering results or data that can drive share prices higher. After an almost ...
Read Full Story »
Pills

Why 1 Analyst Sees Over 50% Upside in Sarepta

Sarepta Therapeutics Inc. (NASDAQ: SRPT) received a favorable rating from Merrill Lynch, and as a result the stock was climbing in Tuesday’s trading session. The firm raised its rating to ...
Read Full Story »
research

Analyst Sees BioMarin Up Another 25%

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) received a favorable analyst call from Merrill Lynch in Monday’s trading session. The brokerage firm reinstated a Buy rating for the stock with a $117 ...
Read Full Story »
Biotechnology word cloud

Portfolio Managers Love These 5 Biotech Stocks

If there is one industry that had a busy January, it was biotech. In fact, January set an all-time record for issuance and funds raised in the biotech sector, and ...
Read Full Story »